US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression - Reuters

Reuters | Jan. 28, 2025, 6:27 p.m. | Original
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression Reuters
Brazil Azul says it concluded debt restructuring process - Reuters LVMH considers widening US footprint as CEO Arnault expresses France fatigue - Reuters